New Combination Treatment, Vyxeos, Approved for Acute Myeloid Leukemia

THURSDAY, Aug. 3, 2017 — The combination chemotherapy drug Vyxeos (daunorubicin and cytarabine) has been approved by the U.S. Food and Drug Administration as the first treatment for certain high-risk types of acute myeloid leukemia (AML).
AML is…
Source: Topamax